Considering data from in vitro and in vivo studies, cannabidiol (CBD) seems to be a promising candidate for the treatment of both somatic and psychiatric disorders. NIH.gov
Published 21:02, Wednesday 20 January 2021 GMT ladbible.com
Published Jan 21, 2021,01:17pm EST forbes.com
Published January 21, 2021, 2:59am vice.com
By: Stephen M. Hahn, M.D., Commissioner of Food and Drugs and Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner FDA.gov
MEDICAL COLLEGE OF GEORGIA AT AUGUSTA UNIVERSITY
Cannabis compound inhibits SARS-CoV-2 replication in human lung cells
By Sally Robertson, B.Sc.